Synergistic Biochemical Scaffold Systems for Enhanced Mental Function

Publication ID: 24-11857626_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Biochemical Scaffold Systems for Enhanced Mental Function,” Published Technical Disclosure No. 24-11857626_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857626_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,626.

Summary of the Inventive Concept

This inventive concept integrates biochemical scaffolds with advanced technologies like AI, IoT, blockchain, and nanomaterials to create a powerful system for enhancing mental function and acuity, overcoming the limitations of traditional biochemical scaffold delivery methods.

Background and Problem Solved

The original patent disclosed a method of enhancing mental function and acuity by delivering biochemical scaffolds, but it had limitations in terms of efficacy, tracking, and personalized optimization. The new inventive concept addresses these limitations by combining biochemical scaffolds with cutting-edge technologies to create a more effective, efficient, and personalized system.

Detailed Description of the Inventive Concept

The new system comprises a biochemical scaffold delivery module integrated with an AI-powered cognitive analytics platform to monitor and optimize cognitive performance. The biochemical scaffolds are delivered via a blockchain-secured supply chain and tracked using IoT-enabled sensors. The system also incorporates a nanomaterial-based delivery system for targeted release and a vibrational energy platform integrated with a machine learning algorithm to predict and prevent cellular stress. Additionally, the system includes a transdermal patch with a graphene-based sensor to monitor and adjust dosage.

Novelty and Inventive Step

The new claims introduce a synergistic combination of biochemical scaffolds with advanced technologies, providing a novel and non-obvious solution for enhancing mental function and acuity. The integration of AI, IoT, blockchain, and nanomaterials with biochemical scaffolds creates a new and innovative system that overcomes the limitations of traditional delivery methods.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of advanced technologies, such as augmented reality or 5G networks, to enhance the system's functionality. Variations could also include using different types of biochemical scaffolds or delivery methods, such as oral or injectable forms.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare, wellness, and education industries, where enhanced mental function and acuity are highly valued. The system could be marketed as a premium product for individuals seeking to improve their cognitive abilities, or as a tool for healthcare professionals to improve patient outcomes.

CPC Classifications

SectionClassGroup
A A61 A61K41/0004
A A61 A61K31/197
A A61 A61K31/4188
A A61 A61K31/4415
A A61 A61K31/455
A A61 A61K31/51
A A61 A61K31/519
A A61 A61K31/525
A A61 A61K31/661
A A61 A61K31/714
A A61 A61K36/06
A A61 A61K36/23
A A61 A61K36/68
A A61 A61K36/9068

Field of Art

Biochemical and pharmaceutical compositions for cognitive enhancement, with expertise in neurological supplement formulation, biotechnology, and advanced drug delivery systems

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in biochemistry, pharmacology, or neuroscience, possessing knowledge of supplement design, cellular biochemistry, and emerging technologies for targeted drug delivery

Obviousness Rationale

A PHOSITA would recognize that integrating advanced technologies with existing biochemical scaffold approaches represents a predictable extension of known cognitive enhancement methodologies. The combination of AI, IoT, and nanomaterial delivery systems with established biochemical compositions follows standard innovation pathways in pharmaceutical and biotechnology domains. The PTD's variations demonstrate incremental technological improvements that would be obvious to a skilled practitioner seeking to optimize cognitive function enhancement techniques.

Obvious Combinations & Variations

Source Patent Element
Liquid composition with glycerin-based water and specific herbal extracts for mental function enhancement
PTD Variation
Adding nanomaterial-based targeted delivery system for biochemical scaffolds
Obviousness Reasoning
Known techniques in drug delivery suggest using nanomaterials to improve bioavailability and targeted release of herbal compounds, representing a predictable technological improvement
Source Patent Element
Biochemical scaffold composition for mental acuity
PTD Variation
Integrating AI-powered cognitive analytics platform to monitor performance
Obviousness Reasoning
Applying machine learning and analytics to supplement effectiveness is a standard approach in personalized medicine and nutritional science
Source Patent Element
Method of delivering biochemical compounds to enhance mental function
PTD Variation
Blockchain-secured supply chain and IoT-enabled tracking of biochemical scaffolds
Obviousness Reasoning
Implementing blockchain and IoT for supply chain management and tracking represents a known technological solution for improving pharmaceutical product monitoring
Source Patent Element
Composition including waterhyssop and gotu kola for cognitive enhancement
PTD Variation
Incorporating graphene-based transdermal sensor for dosage monitoring
Obviousness Reasoning
Using advanced sensor technologies for pharmaceutical dosage tracking is a predictable innovation in personalized medicine and supplement delivery
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this Published Technical Disclosure would be considered obvious to a Person Having Ordinary Skill In The Art in light of US Patent 11857626, as the claimed innovations represent predictable technological extensions combining known biochemical compositions with emerging digital and nanomaterial delivery technologies.

Original Patent Information

Patent NumberUS 11,857,626
TitleMethod of enhancing mental function and acuity by delivering biochemical scaffolds
Assignee(s)Next2Me, LLC